Document Type : Original Article
Authors
1 Department of Biostatistics and Epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran
2 Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
3 Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Abstract
Background: Hypertension is an important cause of cardiovascular-related morbidity and mortality. This study aimed to evaluate the effect of demographic, biochemical, and lifestyle variables on hypertension in the last five years in Kerman, Iran.
Methods: About 2055 adults were randomly selected through single-stage cluster sampling. Demographic characteristics, biochemical variables, tobacco use, opium use, mood, and physical activity were examined. The effect of the studied variables on hypertension was also measured. COPY methods were used to estimate relative risk (RR) and create confidence intervals. All statistical analysis were done in R 4.4.1.
Results: Based on the results obtained using the multivariable COPY method for hypertension, the effects of age, education, physical activity, diabetes, obesity, smoking, anxiety, and depression were significant. It was also found that people with a family history of hypertension and a history of diabetes, obesity, and smoking are at higher risk for hypertension.
Conclusion: The present study showed that the results of this study can be effective in designing and implementing intervention programs for the control and prevention of hypertension in this area.
Keywords
Main Subjects
- Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: a cross-sectional study in urban Varanasi. Int J Hypertens. 2017;2017:5491838. doi: 10.1155/2017/5491838.
- Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension. 2006;48(2):254-9. doi: 10.1161/01.HYP.0000227507.69230.fc.
- Asgary S, Keshvari M. Effects of Citrus sinensis juice on blood pressure. ARYA Atheroscler. 2013;9(1):98-101.
- Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999- 2000. J Hum Hypertens. 2002;16(5):305-12. doi: 10.1038/ sj.jhh.1001399 .
- Sadeghi M, Roohafza HR, Kelishadi R. High blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme. Med J Malaysia. 2004;59(4):460-7.
- Keshvari M, Taleghani F, Shahriari M, Baghersad Z. The relationship between hypertension and its related risk factors in people over 30 years of age in Isfahan. J Community Health. 2018;12(3):20-7. doi: 10.22123/chj.2019.127490.1123. [Persian].
- Pitsavos C, Milias GA, Panagiotakos DB, Xenaki D, Panagopoulos G, Stefanadis C. Prevalence of self-reported hypertension and its relation to dietary habits, in adults; a nutrition & health survey in Greece. BMC Public Health. 2006;6:206. doi: 10.1186/1471-2458-6-206.
- Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980-2012: a systematic review. J Tehran Heart Cent. 2016;11(4):159-67.
- MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765-74. doi: 10.1016/0140-6736(90)90878-9.
- Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153(5):578-81.
- Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989;13(5 Suppl):I80-93. doi: 10.1161/01.hyp.13.5_suppl.i80.
- Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25(3):305-13. doi: 10.1161/01.hyp.25.3.305.
- Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor M, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620-6. doi: 10.1038/ajh.2008.154.
- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982-1004. doi: 10.1097/ hjh.0000000000002453.
- Jafari Oori M, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi A, Ghanei Gheshlagh R. Prevalence of HTN in Iran: meta-analysis of published studies in 2004-2018. Curr Hypertens Rev. 2019;15(2):113-22. doi: 10.2174/157340211 5666190118142818.
- Najafipour H, Mirzazadeh A, Haghdoost A, Shadkam M, Afshari M, Moazenzadeh M, et al. Coronary artery disease risk factors in an urban and peri-urban setting, Kerman, Southeastern Iran (KERCADR study): methodology and preliminary report. Iran J Public Health. 2012;41(9):86-92.
- Najafipour H, Yousefzadeh G, Baneshi MR, Gohari MA, Shahouzehi B, Farokhi MS, et al. Prevalence and 5-year incidence rate of dyslipidemia and its association with other coronary artery disease risk factors in Iran: Results of the Kerman coronary artery disease risk factors study (Phase 2). J Res Med Sci 2021;26:99. doi: 10.4103/jrms.JRMS_748_20.
- 1. Najafipour H, Nasri HR, Rostamzadeh F, Amirzadeh R, Shadkam M, Mirzazadeh A. Prevalence and incidence of prehypertension and hypertension (awareness/control) in Iran: findings from Kerman coronary artery diseases risk factors study 2 (KERCADRS). J Hum Hypertens 2022;36(5):461-72. doi: 10.1038/s41371-020-00392-5.
- Leggio M, Lombardi M, Caldarone E, Severi P, D’Emidio S, Armeni M, et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res. 2017;40(12):947-63. doi: 10.1038/ hr.2017.75.
- Najafipour H, Yeganeh Hajahmadi M, Nasri H, Sadeghi Z. Effect of opium addiction and six other risk factors on hypertension: A population-based study in 5900 adults in Kerman. Iranian Journal of Physiology and Pharmacology. 2017;1(4):241-32.
- Asferg C, Møgelvang R, Flyvbjerg A, Frystyk J, Jensen JS, Marott JL, et al. Interaction between leptin and leisure-time physical activity and development of hypertension. Blood Press. 2011;20(6):362-9. doi: 10.3109/00365599.2011.586248.
- Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344(8916):156-9. doi: 10.1016/s0140- 6736(94)92757-x.
- Bakker EA, Sui X, Brellenthin AG, Lee DC. Physical activity and fitness for the prevention of hypertension. Curr Opin Cardiol. 2018;33(4):394-401. doi: 10.1097/hco.0000000000000526.
- Sulam M. Correlation between nutritional status and waist circumference with the incidence of hypertension in the elderly. J Berk Epidemiologi. 2020;8(1):81-8. doi: 10.20473/ jbe.V8I12020.81-88.
- Amelia R, Harahap J. The role of nutritional status, age, genetic factors, and lifestyle on the hypertension prevalence among community in Indonesian coastal area. Int J Adv Sci Eng Inf Technol. 2019;9(4):1420-6. doi: 10.18517/ijaseit.9.4.5823.
- Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med. 2002;64(5):758-66. doi: 10.1097/01.psy.0000031578.42041.1c.
)